NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Solasia Pharma K.K (F: 9SO)

 
9SO Technical Analysis
5
As on 8th Jan 2026 9SO STOCK Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.20 & Strong Sell for SHORT-TERM with Stoploss of 0.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

9SOSTOCK Price

Open 0.14 Change Price %
High 0.14 1 Day -0.04 -22.22
Low 0.14 1 Week 0.00 0.00
Close 0.14 1 Month -0.01 -6.67
Volume 100 1 Year -0.19 -57.58
52 Week High 0.33 | 52 Week Low 0.13
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
BN5 0.00 %
BN5 0.00 %
WHL 5150.00 -0.44%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
NT5 1000000.00 4629529.50%
30T 1000000.00 3759298.50%
 
F Germany Top Losers Stocks
OBD 0.00 -100.00%
OBD 0.00 -100.00%
OBD 0.00 -100.00%
OBD 0.00 -100.00%
OBD 0.00 -100.00%
M2G 0.00 -100.00%
M2G 0.00 -100.00%
M2G 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
 
 
9SO
Daily Charts
9SO
Intraday Charts
Whats New @
Bazaartrend
9SO
Free Analysis
 
9SO Important Levels Intraday
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
RESISTANCE0.14
 
9SO Forecast January 2026
4th UP Forecast0.27
3rd UP Forecast0.23
2nd UP Forecast0.2
1st UP Forecast0.18
1st DOWN Forecast0.1
2nd DOWN Forecast0.08
3rd DOWN Forecast0.05
4th DOWN Forecast0.01
 
9SO Weekly Forecast
4th UP Forecast0.18
3rd UP Forecast0.17
2nd UP Forecast0.16
1st UP Forecast0.15
1st DOWN Forecast0.13
2nd DOWN Forecast0.12
3rd DOWN Forecast0.11
4th DOWN Forecast0.10
 
9SO Forecast2026
4th UP Forecast0.53
3rd UP Forecast0.4
2nd UP Forecast0.33
1st UP Forecast0.25
1st DOWN Forecast0.03
2nd DOWN Forecast-0.05
3rd DOWN Forecast-0.12
4th DOWN Forecast-0.25
 
 
9SO Other Details
Segment EQ
Market Capital 112303960.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
9SO Address
9SO
 
9SO Latest News
 
Your Comments and Response on Solasia Pharma K.K
 
9SO Business Profile
Solasia Pharma K.K. develops and commercializes drugs in the field of oncology in Japan and other Asian countries. The company offers SP-03 (episil oral liquid) for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; and SP-01 (Sancuso), a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting. It is also developing SP-02 (Darinaparsin), a mitochondrial-targeted agent that has completed phase III clinical study to treat various hematologic and solid cancers; and SP-04 (PledOx), an intracellular superoxide removing agent, which is in phase IIb clinical trials for chemotherapy induced peripheral neuropathy. In addition, the company is developing SP-05 (Arfolitixorin) that is in phase III clinical study for the enhancement of antitumor efficacy of fluorouracil, including the treatment for pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers. Solasia Pharma K.K. was founded in 2006 and is based in Tokyo, Japan. Address: Sumitomo Fudosan Shiba-Koen Tower, Tokyo, Japan, 105-0011
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service